Study title: An Open-label Trial Evaluating the Safety and Efficacy of NOLVADEX (tamoxifen citrate) in the Treatment of McCune-Albright SyndromeAn Open-label Trial Evaluating the Safety and Efficacy of NOLVADEX (tamoxifen citrate) in the Treatment of McCune-Albright Syndrome
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Musculoskeletal Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: TAMOXIFEN | |||||
ATC code: L02BA01 | |||||
Document link: 6157US0013 CSR Synopsis[1].pdf | |||||
Document date: 2011-08-15 | |||||
Study number: 6157US/0013 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |